In VivoBioBytes presents an overview of select AI-focused M&As, partnerships and financings in the biopharma industry in Q2 2025. While the flow of money was mostly anemic, a couple of standouts are a $2
ScripThe Bill and Melinda Gates Foundation spent $100bn on public health and anti-poverty initiatives globally during its first 25 years, including investments in private biotechnology companies working in